Effect of Probiotics in Alzheimer's Disease

In this clinical trial, five strains of probiotics (Bifidobacterium breve Bv-889, B. longum subspecies infantis BLI-02, B. bifidum VDD088, B. animalis subsp. lactis CP-9, Lactobacillus plantarum PL-02) with anti-oxidant and anti-inflammatory functions will been applied to slow down the development of the Alzheimer\'s disease through regulating the intestinal flora and immune system of patients with mild to moderate Alzheimer\'s disease symptoms. The efficacy of probiotic treatment against Alzheimer\'s disease will be evaluated.